Finland-based Gosta Labs has secured an oversubscribed €7.5 million seed round to expand its AI Operating System designed for the most complex medical specialties. The investment was led by Voima Ventures, with participation from COR Group Oy, Terveystalo, the Aho family, and additional new and existing backers, including Reaktor and a group of prominent angel investors.
The funding supports the company’s efforts to streamline clinician workflows across oncology and other high-complexity fields. Gosta Labs’ platform is already in daily use by clinicians in Finland, Switzerland, the Baltics, and Australia. According to the company, real-world results presented at the ESMO 2025 oncology conference show that high-quality oncology documentation can be completed in less than two minutes using its technology. This has helped reduce administrative time by more than two-thirds per patient visit.
Gosta Labs plans to accelerate product development and global scaling, aiming to give care teams more time with patients by reducing documentation burdens. The company said momentum is growing as clinical teams adopt its tools and report significant improvements in efficiency and workflow quality.
KEY QUOTE:
“Gosta Labs’ key team members combine proven startup execution, deep domain expertise and top notch AI capabilities. They’ve done it before and know what good looks like, which is an essential for any startup team. There’s a lot of hype around AI but Gosta delivers the value it promises and customers love the product.”
Jussi Sainiemi, Partner at Voima Ventures
